Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Byrna Technologies (BYRN) Asset Writedowns and Impairment (2020 - 2026)

Byrna Technologies (BYRN) has disclosed Asset Writedowns and Impairment for 6 consecutive years, with $360000.0 as the latest value for Q1 2026.

  • Quarterly Asset Writedowns and Impairment changed N/A to $360000.0 in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $184000.0 through Feb 2026, up 50.82% year-over-year, with the annual reading at -$244000.0 for FY2025, 38.64% down from the prior year.
  • Asset Writedowns and Impairment for Q1 2026 was $360000.0 at Byrna Technologies, up from -$176000.0 in the prior quarter.
  • The five-year high for Asset Writedowns and Impairment was $360000.0 in Q1 2026, with the low at -$176000.0 in Q4 2024.
  • Average Asset Writedowns and Impairment over 4 years is $98800.0, with a median of $178000.0 recorded in 2022.
  • The sharpest move saw Asset Writedowns and Impairment skyrocketed 841.67% in 2022, then plummeted 159.06% in 2024.
  • Over 4 years, Asset Writedowns and Impairment stood at $178000.0 in 2022, then soared by 67.42% to $298000.0 in 2023, then tumbled by 159.06% to -$176000.0 in 2024, then surged by 304.55% to $360000.0 in 2026.
  • According to Business Quant data, Asset Writedowns and Impairment over the past three periods came in at $360000.0, -$176000.0, and $298000.0 for Q1 2026, Q4 2024, and Q4 2023 respectively.